Insider Selling: CME Group Inc (CME) Insider Sells 1,823 Shares of Stock
CME Group Inc (NASDAQ:CME) insider Hilda Harris Piell sold 1,823 shares of the stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $175.00, for a total value of $319,025.00. Following the completion of the transaction, the insider now directly owns 30,176 shares in the company, valued at approximately $5,280,800. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Shares of CME traded up $0.24 during trading hours on Friday, reaching $173.74. The stock had a trading volume of 55,520 shares, compared to its average volume of 1,252,686. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.15. CME Group Inc has a 52 week low of $124.92 and a 52 week high of $177.35. The stock has a market cap of $58.16 billion, a P/E ratio of 36.38, a P/E/G ratio of 3.21 and a beta of 0.64.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, July 26th. The financial services provider reported $1.74 EPS for the quarter, beating the Zacks’ consensus estimate of $1.72 by $0.02. CME Group had a net margin of 111.45% and a return on equity of 9.03%. The business had revenue of $1.06 billion during the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter in the prior year, the company earned $1.22 EPS. The firm’s quarterly revenue was up 14.6% on a year-over-year basis. equities research analysts expect that CME Group Inc will post 6.68 earnings per share for the current fiscal year.
A number of research analysts have recently weighed in on CME shares. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, June 6th. Jefferies Financial Group reissued a “buy” rating and issued a $190.00 price target on shares of CME Group in a research note on Wednesday. Rosenblatt Securities started coverage on CME Group in a research note on Wednesday. They issued a “neutral” rating and a $177.00 price target on the stock. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, August 22nd. Finally, Compass Point started coverage on CME Group in a research note on Monday, July 9th. They issued a “neutral” rating and a $170.00 price target on the stock. One research analyst has rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company’s stock. CME Group presently has an average rating of “Buy” and an average target price of $174.40.
Several institutional investors and hedge funds have recently added to or reduced their stakes in CME. Meeder Asset Management Inc. increased its holdings in CME Group by 84.8% during the 2nd quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock worth $129,000 after purchasing an additional 362 shares in the last quarter. Kaizen Advisory LLC increased its holdings in CME Group by 151.9% during the 2nd quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock worth $134,000 after purchasing an additional 492 shares in the last quarter. Signaturefd LLC bought a new position in CME Group during the 1st quarter worth about $138,000. Old Mutual Global Investors UK Ltd. bought a new position in CME Group during the 1st quarter worth about $138,000. Finally, McKinley Carter Wealth Services Inc. bought a new position in CME Group during the 1st quarter worth about $142,000. Institutional investors and hedge funds own 84.03% of the company’s stock.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.